About Pranaya Group
Pranaya Group was a company based in Hyderabad (India) founded in 2020. It serves as a cdmo focused on manufacturing of apis. pranaya group has raised 898k in funding, with last known valuation of 907k. Pranaya Group has raised $897.96 thousand across 1 funding round from investors including Kanigiri Gade. Pranaya Group was last valued at $906.58 thousand in January 2021. The company is recorded as dissolved. Its legal entity in India is Pranaya Pharmaceuticals Private Limited (U24239TG2020PTC139841). Its competitors include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed competitors have raised funding.
Company details
It serves as a cdmo focused on manufacturing of apis. pranaya group has raised 898k in funding, with last known valuation of 907k.
- Headquarters Hyderabad, India
- Website pranayagroup.com
- Legal Name Pranaya Pharmaceuticals Private Limited
- Date of Incorporation 17 Mar, 2020
- Jurisdiction Hyderabad, Telangana, India
- Net Loss-₹7.9 Lakh
FY 2022 · 0% margin
- EBITDA-₹6.9 Lakh
FY 2022 · 0% margin
- Total Equity Funding$897.96K (USD)
in 1 rounds
- Latest Funding Round$897.96K (USD), Angel Round
Jan 2021
Associated legal entities of Pranaya Group
Pranaya Group operates through Pranaya Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pranaya Pharmaceuticals Private Limited CIN U24239TG2020PTC139841 | Active | 17 Mar 2020 | R.C.Puram, Telangana | 13 | 3 | View details |
Funding Insights of Pranaya Group
Pranaya Group has successfully raised a total of $897.96K through 1 strategic funding round. The most recent funding activity was a Angel Round of $897.96 thousand completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $897,956
- Total Rounds 1
- Last Round Angel Round — $897,956
- First Round $897,956
(Jan 2021)
- Investors Count 1
All 1 funding rounds of Pranaya Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $897,956 | Angel Round | $906,575 | Kanigiri Gade | – |
Last known valuation $906,575 (Jan 2021). 1 investors in total: 0 institutional and 1 angel.
Investors in Pranaya Group
Pranaya Group has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Kanigiri Gade.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
KG Kanigiri Gade | unknown_4e7b8d2695054cd6a |
Investor details for Pranaya Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Pranaya Pharmaceuticals Private Limited (Pranaya Group)
Pranaya Pharmaceuticals Private Limited is the primary company behind Pranaya Group. The board of Pranaya Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Kumaraswamy Reddy Maruri, appointed in 2023. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kumaraswamy Reddy Maruri DIN 09814740 | Director | 22 May 2023 | 3 yrs 5 mo | Pranaya Pharmaceuticals Private Limited |
| Sivaramakrishnareddy Pathuri DIN 08686258 | Additional Director | 25 Jul 2024 | 2 yrs 3 mo | Pranaya Pharmaceuticals Private Limited |
| Satyanarayana Reddy DIN 07413680 | Additional Director | 25 Jul 2024 | 2 yrs 3 mo | Pranaya Pharmaceuticals Private Limited |
Financials of Pranaya Group
Figures of Pranaya Pharmaceuticals Private Limited, the primary company behind Pranaya Group, for FY 2022. Net loss was -₹7.9 Lakh (0% margin). EBITDA was -₹6.9 Lakh (0% margin).
- -₹7.9 LakhNet loss · 0% margin
- -₹6.9 LakhEBITDA · 0% margin
- ₹1.00 CrPaid-up capital
- 13Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Pranaya Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Pranaya Group
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Pranaya Group
2 dated milestones of Pranaya Group across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Pranaya Group is founded.
- Funding First funding round of $898K.
Competitors of Pranaya Group
Pranaya Group has 3 listed competitors in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed competitors of Pranaya Group
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pranaya Group
Pranaya Group was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Pranaya Group is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Pranaya Group is a funded company, having raised a total of $897.96K across 1 funding round to date. The company's 1st funding round was a Angel Round of $897.96K, raised on Jan 2021.
It serves as a cdmo focused on manufacturing of apis. pranaya group has raised 898k in funding, with last known valuation of 907k.
Pranaya Group's top competitors include Laurus Labs, Symbiotec and SeQuent.
Pranaya Group has 1 investor. Key investors include Kanigiri Gade.
The valuation of Pranaya Group is $906.58K as of Jan 2021.
Pranaya Group operates through Pranaya Pharmaceuticals Private Limited.
The legal entities of Pranaya Group currently have 3 directors, including Kumaraswamy Reddy Maruri, Sivaramakrishnareddy Pathuri, Satyanarayana Reddy.